Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 61337-89-1
2. 2-(4-methyl-2-phenyl-1-piperazinyl)-3-pyridinemethanol
3. 337376-18-8
4. (2-(4-methyl-2-phenylpiperazin-1-yl)pyridin-3-yl)methanol
5. 1-(3-hydroxymethylpyridyl-2)-2-phenyl-4-methylpyperazine
6. [2-(4-methyl-2-phenylpiperazin-1-yl)pyridin-3-yl]methanol
7. Xro2ge880o
8. 3-pyridinemethanol, 2-(4-methyl-2-phenyl-1-piperazinyl)-
9. 2-(4-methyl-2-phenylpiperazin-1-yl)pyridine-3-methanol
10. 1-(3-(hydroxymethyl)pyridin-2-yl)-4-methyl-2-phenylpiperazine
11. 1-(3-hydroxymethyl Pyridin-2-yl)-4-methyl-2-phenyl Piperazine
12. [2-[(2rs)-4-methyl-2-phenylpiperazin-1-yl]pyridin-3-yl]methanol
13. Mirtazapine Impurity B
14. Unii-xro2ge880o
15. Ec 700-296-8
16. 2-(4-methyl-2-phenylpiperazino)pyridine-3-methanol
17. Acyclomirtazapine Alcohol
18. Schembl1325599
19. 1-(3-hydroxidmethylpyridine)-2-phenyl-4-methyl-piperazine
20. 1-(3-hydroxymethyl-2-pyridyl)-4-methyl-2-phenylpiperazine
21. Dtxsid901036336
22. Amy40875
23. Mfcd08063948
24. Akos010505275
25. Diethyl3,4-pyrroledicarboxylate
26. Ac-15710
27. Ac-23364
28. Ds-10746
29. Db-018516
30. Db-053847
31. Cs-0313951
32. Ft-0640747
33. Ft-0727774
34. Mirtazapine Impurity B [ep Impurity]
35. F14603
36. 337m891
37. A868737
38. A875208
39. 1-(3-hydroxymethylpyridyl-2)-4-methyl-2-phenyl-piperazine
40. 1-(3-hydroxymethyl Pyridin-2-yl)-4-methyl-2-phenylpiperazine
41. 1-(3-hydroxymethyl Pyridyl-2)-4-methyl-2-phenyl-piperazine
42. 1-(3-hydroxymethylpyridin-2-yl)-4-methyl-2-phenyl Piperazine
| Molecular Weight | 283.37 g/mol |
|---|---|
| Molecular Formula | C17H21N3O |
| XLogP3 | 1.8 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 3 |
| Exact Mass | 283.168462302 g/mol |
| Monoisotopic Mass | 283.168462302 g/mol |
| Topological Polar Surface Area | 39.6 Ų |
| Heavy Atom Count | 21 |
| Formal Charge | 0 |
| Complexity | 319 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Mirtazapine Impurity B manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mirtazapine Impurity B, including repackagers and relabelers. The FDA regulates Mirtazapine Impurity B manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mirtazapine Impurity B API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Mirtazapine Impurity B supplier is an individual or a company that provides Mirtazapine Impurity B active pharmaceutical ingredient (API) or Mirtazapine Impurity B finished formulations upon request. The Mirtazapine Impurity B suppliers may include Mirtazapine Impurity B API manufacturers, exporters, distributors and traders.
click here to find a list of Mirtazapine Impurity B suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Mirtazapine Impurity B written confirmation (Mirtazapine Impurity B WC) is an official document issued by a regulatory agency to a Mirtazapine Impurity B manufacturer, verifying that the manufacturing facility of a Mirtazapine Impurity B active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Mirtazapine Impurity B APIs or Mirtazapine Impurity B finished pharmaceutical products to another nation, regulatory agencies frequently require a Mirtazapine Impurity B WC (written confirmation) as part of the regulatory process.
click here to find a list of Mirtazapine Impurity B suppliers with Written Confirmation (WC) on PharmaCompass.
Mirtazapine Impurity B Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Mirtazapine Impurity B GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Mirtazapine Impurity B GMP manufacturer or Mirtazapine Impurity B GMP API supplier for your needs.
A Mirtazapine Impurity B CoA (Certificate of Analysis) is a formal document that attests to Mirtazapine Impurity B's compliance with Mirtazapine Impurity B specifications and serves as a tool for batch-level quality control.
Mirtazapine Impurity B CoA mostly includes findings from lab analyses of a specific batch. For each Mirtazapine Impurity B CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Mirtazapine Impurity B may be tested according to a variety of international standards, such as European Pharmacopoeia (Mirtazapine Impurity B EP), Mirtazapine Impurity B JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Mirtazapine Impurity B USP).
LOOKING FOR A SUPPLIER?
